10/05/2026
AND HERE WE GO AGAIN!
ANOTHER DRUG TO ADDRESS WHAT HAPPENS WITH THE FIRST ONE?
THIS IS GETTING INSANE…
Turn on your TV or pull up the internet, and it doesn’t take long to find another advertisement, headline, or story promoting weight-loss drugs and GLP-1 medications as though they’re some kind of miracle solution. Where is that same attention to nutrition education, strength training, and the ongoing support people need to make meaningful changes in their health? Where is the investment in helping people understand their bodies and giving them the tools to improve how they eat, move, and live?
I just read an article about an experimental RNA therapy being studied alongside semaglutide to help preserve lean mass while producing greater fat loss. Researchers are investigating another pharmaceutical intervention to address a concern that deserves a serious conversation whenever someone begins losing weight: what kind of weight are they losing, and what are we doing to protect their muscle?
Let’s be clear about what this research actually shows. The treatment was tested in mice, and the combination reportedly reduced lean-mass loss from roughly 10% with semaglutide alone to 5.5%. That’s a reduction in the amount lost, not complete prevention of loss. These findings don’t establish that the treatment is safe, effective, or sustainable in people, and the article acknowledges that significant work remains before it could become a human treatment.
There’s another distinction readers deserve to understand. Lean mass isn’t the same thing as muscle, it includes water, organs, bone, and other tissues. A change in lean mass alone doesn’t tell us exactly how much skeletal muscle was lost or whether strength and physical function were preserved. If we’re discussing muscle protection, those outcomes deserve attention too.
What bothered me most was what the article left out. There was no meaningful discussion of structured resistance training, adequate protein and overall nutrition, or the coaching needed to help people consistently put those things into practice. An entire article about preserving muscle during weight loss, and the intervention getting the spotlight is another experimental drug.
Nutrition and resistance training aren’t fringe ideas in this conversation. A joint advisory from four professional societies specifically identifies appropriate diet and resistance training as priorities for preserving muscle and bone during GLP-1 treatment. Readers deserve to know about those established priorities alongside the experimental therapy, especially when the concern being discussed is the very issue those recommendations address.
This is where we need to stop confusing disease management with a cure. A medication can produce meaningful improvements while someone takes it, but those improvements don’t automatically establish that the underlying condition has been permanently resolved. People deserve to understand what a treatment accomplishes, what its limitations are, and what may happen when it stops. That conversation should be part of informed decision-making from the beginning.
Nutrition and exercise deserve that same honesty. They aren’t a guaranteed cure for every chronic disease, but their value extends far beyond a smaller number on the scale. Strength, physical capacity, food quality, and sustainable habits belong at the center of a serious health plan, and simply telling someone to “eat better and exercise” before moving on to the prescription doesn’t provide the guidance needed to put that advice into practice.
After more than 45 years of coaching, I know that information alone doesn’t create change. People need to understand what to do, why it matters, and how to make it work in their lives. They need a plan that fits their abilities, guidance as they progress, and someone helping them stay consistent. That takes time and effort, and it deserves serious investment.
I’m increasingly disgusted by coverage that gives the next pharmaceutical development so much attention while leaving practical nutrition and exercise interventions out of the conversation. Before we celebrate another drug as the next answer, where is the equally serious commitment to making nutrition education, strength training, and sustained coaching accessible? If improving health is the goal, helping people put those interventions into practice should be a priority, with resources and support to match.